Glaukos (GKOS) Change in Accured Expenses (2014 - 2026)
Glaukos (GKOS) posted quarterly Change in Accured Expenses of $12.4 million for Q2 2026, up 87.23% year-over-year from $6.6 million in Q2 2025, and up 221.54% quarter-over-quarter from -$10.2 million in Q1 2026.
Glaukos (GKOS) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Change in Accured Expenses for 13 consecutive years, with $12.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Accured Expenses rose 87.23% year-over-year to $12.4 million; the TTM figure through Jun 2026 stood at $21.1 million (up 333.12% YoY), while the FY2025 annual figure was $18.8 million, up 89538.1% from the prior year.
- Change in Accured Expenses rose to $12.4 million in Q2 2026 per GKOS's latest filing, from -$10.2 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $15.9 million in Q2 2022 and bottomed at -$10.2 million in Q3 2022.
- Historically, Change in Accured Expenses has averaged $1.6 million across 5 years, with a median of $2.0 million in 2023.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses sank 421.62% — and 2025, when it soared 1280.35%.
- Glaukos' Change in Accured Expenses stood at $9.1 million in 2022, then retreated by 17.7% to $7.5 million in 2023, then tumbled by 40.61% to $4.4 million in 2024, then soared by 151.59% to $11.1 million in 2025, then rose by 11.21% to $12.4 million in 2026.
- Business Quant data shows GKOS's Change in Accured Expenses at $12.4 million in Q2 2026, -$10.2 million in Q1 2026, and $11.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Glaukos | 11.03 Bn | 10.92 Bn | 151.59 Mn | 12.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.39 Mn |
| Jun 30, 2026 | 12.39 Mn |
| Mar 31, 2026 | -10.19 Mn |
| Mar 31, 2026 | -10.19 Mn |
| Dec 31, 2025 | 11.14 Mn |
| Dec 31, 2025 | 11.14 Mn |
| Sep 30, 2025 | 7.80 Mn |
| Sep 30, 2025 | 7.80 Mn |
| Jun 30, 2025 | 6.62 Mn |
| Jun 30, 2025 | 6.62 Mn |
| Mar 31, 2025 | -6.73 Mn |
| Mar 31, 2025 | -6.73 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 565,000.00 |
| Sep 30, 2024 | 565,000.00 |
| Jun 30, 2024 | -1.35 Mn |
| Jun 30, 2024 | -1.35 Mn |
| Mar 31, 2024 | -3.62 Mn |
| Mar 31, 2024 | -3.62 Mn |